A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate
Clinical trial NCT01636843 · TERMINATED
Trial details
- NCT number
- NCT01636843
- Sponsor
- Novo Nordisk A/S
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-30
- Primary completion
- 2014-11-10
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.